脓毒症低脂蛋白亚型中脂质失调的多组学分子模式:休克发生率和死亡率更高
该研究分析四项成人脓毒症研究数据(288例),并将发现置于两个外部数据集(合计824例)中验证。既往定义的低脂蛋白(HYPO)亚型占43%,其SOFA评分中位数更高(9 vs 5,p<0.001)、升压药使用更多(67% vs 34%,p<0.001)、28天死亡率更高(30% vs 16%,p=0.004)。白细胞RNA测序发现HYPO患者7个脂质代谢基因上调(PCSK9、DHCR7、LDLR、ALOX5、PLTP、FDFT1、MSMO1),脂质组学显示胆固醇酯、溶血磷脂酰胆碱、鞘磷脂降低。外部数据集验证了7个基因中的6个(PCSK9、DHCR7、ALOX5、PLTP、LDLR、MSMO1),提示HYPO脓毒症具有可识别的脂质失调分子特征。
要点
- 脓毒症HYPO亚型占43%,其SOFA评分中位数9 vs NORMO 5(p<0.001),升压药使用67% vs 34%(p<0.001)。
- HYPO亚型28天死亡率30% vs NORMO 16%(p=0.004),提示该亚型预后更差。
- HYPO患者白细胞RNAseq显示7个脂质代谢基因上调:PCSK9、DHCR7、LDLR、ALOX5、PLTP、FDFT1、MSMO1。
- 脂质组学显示HYPO患者胆固醇酯(校正p<0.001)、溶血磷脂酰胆碱(校正p=0.001)、鞘磷脂(校正p<0.001)降低。
- 外部数据集(合计824例)验证了7个上调基因中的6个:PCSK9、DHCR7、ALOX5、PLTP、LDLR、MSMO1。
适用人群与场景
- 四项成人脓毒症研究的数据,纳入288例患者,其中HYPO亚型43%、NORMO亚型57%。
- 外部验证数据集合计824例患者。
诊断标准与关键阈值
- 既往已定义的脂质失调亚型:低脂蛋白(HYPO)亚型表现为低脂蛋白、死亡率增加;正常脂蛋白(NORMO)亚型表现为较高脂蛋白、较低死亡率。
研究设计与关键结果
- 研究类型:对四项成人脓毒症研究数据的分析,并在两个外部数据集中验证发现。
- 288例患者中HYPO占43%、NORMO占57%;HYPO患者SOFA评分中位数9 vs 5(p<0.001)、升压药使用67% vs 34%(p<0.001)、28天死亡率30% vs 16%(p=0.004)。
- 白细胞RNAseq(脓毒症24小时内采集)发现HYPO患者7个脂质代谢基因上调:PCSK9、DHCR7、LDLR、ALOX5、PLTP、FDFT1、MSMO1。
- 脂质组学显示HYPO患者胆固醇酯降低(校正p<0.001)、溶血磷脂酰胆碱降低(校正p=0.001)、鞘磷脂降低(校正p<0.001)。
- 在HYPO患者中,DHCR7表达与胆固醇酯、溶血磷脂酰胆碱、鞘磷脂降低强相关(p<0.01);PCSK9、MSMO1、DHCR7、PLTP、LDLR上调与低溶血磷脂酰胆碱相关(p<0.05);DHCR7、ALOX5、LDLR与鞘磷脂降低相关(p<0.05)。
- 两个外部数据集(合计824例)的死亡率和表型比较验证了7个上调基因中的6个:PCSK9、DHCR7、ALOX5、PLTP、LDLR、MSMO1。
证据类型、等级与局限
- 证据类型:对四项成人脓毒症研究数据的分析,并在两个外部数据集中验证。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Lipids play a critical role in defense against sepsis. We sought to investigate gene expression and lipidomic patterns of lipid dysregulation in sepsis.
METHODS: Data from four adult sepsis studies were analyzed and findings were investigated in two external datasets. Previously characterized lipid dysregulation subphenotypes of hypolipoprotein (HYPO; low lipoproteins, increased mortality) and normolipoprotein (NORMO; higher lipoproteins, lower mortality) were studied. Leukocytes collected within 24 h of sepsis underwent RNA sequencing (RNAseq) and shotgun plasma lipidomics was performed.
RESULTS: Of 288 included patients, 43% were HYPO and 57% were NORMO. HYPO patients exhibited higher median SOFA scores (9 vs 5, p = < 0.001), vasopressor use (67% vs 34%, p = < 0.001), and 28-day mortality (30% vs 16%, p = 0.004). Leukocyte RNAseq identified seven upregulated lipid metabolism genes in HYPO (PCSK9, DHCR7, LDLR, ALOX5, PLTP, FDFT1, and MSMO1) vs. NORMO patients. Lipidomics revealed lower cholesterol esters (CE, adjusted p = < 0.001), lysophosphatidylcholines (LPC, adjusted p = 0.001), and sphingomyelins (SM, adjusted p = < 0.001) in HYPO patients. In HYPO patients, DHCR7 expression strongly correlated with reductions in CE, LPC, and SM (p < 0.01), while PCSK9, MSMO1, DHCR7, PLTP, and LDLR upregulation were correlated with low LPC (p < 0.05). DHCR7, ALOX5, and LDLR correlated with reductions in SM (p < 0.05). Mortality and phenotype comparisons in two external datasets (N = 824 combined patients) corroborated six of the seven upregulated lipid genes (PCSK9, DHCR7, ALOX5, PLTP, LDLR, and MSMO1).
CONCLUSION: We identified a genetic lipid dysregulation signature characterized by seven lipid metabolism genes. Five genes in HYPO sepsis patients most strongly correlated with low CE, LPC, and SMs that mediate cholesterol storage and innate immunity.
参考来源
- Augustin B, Wu D, Black LP, et al. Multiomic molecular patterns of lipid dysregulation in a subphenotype of sepsis with higher shock incidence and mortality. Crit Care. 2024. PMID: 39716214. doi:10.1186/s13054-024-05216-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。